205 related articles for article (PubMed ID: 24966587)
21. Comparison of the efficacy of Lamivudine plus adefovir versus entecavir in the treatment of Lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.
Huang ZB; Zhao SS; Huang Y; Dai XH; Zhou RR; Yi PP; Chen RC; Li WT; Zhang BX; Li N; Fan XG
Clin Ther; 2013 Dec; 35(12):1997-2006. PubMed ID: 24238791
[TBL] [Abstract][Full Text] [Related]
22. Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort.
Ahn SS; Chon YE; Kim BK; Kim SU; Kim DY; Ahn SH; Han KH; Park JY
Clin Mol Hepatol; 2014 Sep; 20(3):261-6. PubMed ID: 25320729
[TBL] [Abstract][Full Text] [Related]
23. Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice.
Lampertico P
J Hepatol; 2009 Apr; 50(4):644-7. PubMed ID: 19231017
[No Abstract] [Full Text] [Related]
24. Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?
Sonneveld MJ; Janssen HL
Liver Int; 2011 Jan; 31 Suppl 1():78-84. PubMed ID: 21205142
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.
Wu IT; Hu TH; Hung CH; Lu SN; Wang JH; Lee CM; Chen CH
Clin Microbiol Infect; 2017 Jul; 23(7):464-469. PubMed ID: 28189857
[TBL] [Abstract][Full Text] [Related]
26. Tenofovir is superior to entecavir for achieving complete viral suppression in HBeAg-positive chronic hepatitis B patients with high HBV DNA.
Gao L; Trinh HN; Li J; Nguyen MH
Aliment Pharmacol Ther; 2014 Mar; 39(6):629-37. PubMed ID: 24467455
[TBL] [Abstract][Full Text] [Related]
27. Comparison of efficacy and safety of tenofovir and entecavir in chronic hepatitis B virus infection: a systematic review and meta-analysis.
Ke W; Liu L; Zhang C; Ye X; Gao Y; Zhou S; Yang Y
PLoS One; 2014; 9(6):e98865. PubMed ID: 24905092
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of 2years of entecavir plus adefovir therapy in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analog treatment.
Wang X; Zhang C; Zhu Y; Xiong Y; Wang Y
Antiviral Res; 2014 Mar; 103():71-7. PubMed ID: 24462954
[TBL] [Abstract][Full Text] [Related]
29. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
Buster EH; Schalm SW; Janssen HL
Best Pract Res Clin Gastroenterol; 2008; 22(6):1093-108. PubMed ID: 19187869
[TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapy of hepatitis B infection: a brief review.
Quan DJ
Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082
[TBL] [Abstract][Full Text] [Related]
31. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
Maratea D; Fadda V; Trippoli S; Messori A
Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
[No Abstract] [Full Text] [Related]
32. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir?
Sadler MD; Lee SS
Aliment Pharmacol Ther; 2014 Jun; 39(11):1339. PubMed ID: 24803253
[No Abstract] [Full Text] [Related]
33. Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs.
Petersen J; Buti M
Expert Rev Gastroenterol Hepatol; 2012 Dec; 6(6):683-93; quiz 694. PubMed ID: 23237254
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and treatment strategy for drug resistances of nucleos(t)ide analogues for chronic hepatitis B].
Hosaka T; Suzuki F; Kumada H
Nihon Shokakibyo Gakkai Zasshi; 2011 Feb; 108(2):210-4. PubMed ID: 21307624
[No Abstract] [Full Text] [Related]
35. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients.
Bradshaw D; Danta M
Aliment Pharmacol Ther; 2014 May; 39(9):992. PubMed ID: 24689343
[No Abstract] [Full Text] [Related]
36. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply.
Gao L; Trinh HN; Li J; Nguyen MH
Aliment Pharmacol Ther; 2014 Jun; 39(11):1339-40. PubMed ID: 24803254
[No Abstract] [Full Text] [Related]
37. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
Park JG; Park SY
Clin Mol Hepatol; 2015 Sep; 21(3):242-8. PubMed ID: 26523269
[TBL] [Abstract][Full Text] [Related]
38. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients--authors' reply.
Gao L; Trinh HN; Li J; Nguyen MH
Aliment Pharmacol Ther; 2014 May; 39(9):993. PubMed ID: 24689344
[No Abstract] [Full Text] [Related]
39. Long-term results of treatment with nucleoside and nucleotide analogues (entecavir and tenofovir) for chronic hepatitis B.
Asselah T; Marcellin P
Clin Liver Dis; 2013 Aug; 17(3):445-50. PubMed ID: 23905815
[TBL] [Abstract][Full Text] [Related]
40. Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis.
Köklü S; Tuna Y; Gülşen MT; Demir M; Köksal AŞ; Koçkar MC; Aygün C; Coban S; Ozdil K; Ataseven H; Akin E; Pürnak T; Yüksel I; Ataseven H; Ibiş M; Yildirim B; Nadir I; Küçükazman M; Akbal E; Yüksel O; Başar O; Alkan E; Baykal O
Clin Gastroenterol Hepatol; 2013 Jan; 11(1):88-94. PubMed ID: 23063679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
